A recent preprint from the same group using another TREM2 agonistic antibody in established atherosclerosis also demonstrated reduced necrotic core formation19, corroborating our conclusions that TREM2 signaling reduces plaque necrosis. Here, TREM2 is linked to atherosclerosis.